Tianyi Medical announced that the 9th meeting of the fourth board of directors of the company reviewed and approved a plan to issue convertible corporate bonds to unspecified targets. The total amount of capital raised to be raised by issuing convertible bonds will not exceed 500 million yuan. The net amount of capital raised after deducting issuance fees is to be invested in Tianyi Medical's high-end pharmaceutical and medical device R&D and production project. The total investment of the project is 791 million yuan, and it is proposed to use capital to raise 500 million yuan. The offering still needs to be reviewed and approved by the company's shareholders' meeting, reviewed and approved by the Shenzhen Stock Exchange, and registered with the China Securities Regulatory Commission before it can be implemented.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.